Free Trial

ABVC BioPharma (ABVC) Institutional Ownership

ABVC BioPharma logo
$2.62 -0.10 (-3.82%)
As of 01:18 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Institutional Ownership Changes (13F Filings) for ABVC BioPharma (NASDAQ:ABVC)

Current
Institutional Ownership
Percentage
11.38%
Number of
Institutional Buyers
(last 12 months)
3
Total
Institutional Inflows
(last 12 months)
$102.88K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$17.35K
Get ABVC Insider Trade Alerts

Want to know when executives and insiders are buying or selling ABVC BioPharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ABVC Institutional Buying and Selling by Quarter

ABVC BioPharma Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/12/2025 XTX Topco Ltd52,625$117K0.0%-12.9%0.310%
8/8/2025 Geode Capital Management LLC110,499$246K0.0%+5.8%0.651%
5/8/2025 XTX Topco Ltd60,439$64K0.0%+75.7%0.360%
2/7/2025 Avantax Planning Partners Inc.143,968$85K0.0%+269.1%1.110%
5/2/2024 Chase Investment Counsel Corp178,377$233K0.1%N/A1.689%
11/16/2021 Squarepoint Ops LLC19,207$44K0.0%N/A0.072%
11/12/2021Credit Suisse AG11,709$27K0.0%N/A0.044%
(Data available from 1/1/2016 forward)

ABVC Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ABVC shares?

During the previous two years, the following institutional investors and hedge funds held shares of ABVC BioPharma shares: Geode Capital Management LLC ($246K), Chase Investment Counsel Corp ($233K), and XTX Topco Ltd ($117K), Avantax Planning Partners Inc. ($85K).Learn more on ABVC BioPharma's institutional investors.

What percentage of ABVC BioPharma's stock is owned by institutional investors?

11.38% of ABVC BioPharma's stock is owned by institutional investors. Learn more on ABVC's institutional investor holdings.

Which institutional investors have been buying ABVC BioPharma's stock?

The following institutional investors have purchased ABVC BioPharma's stock in the last 24 months: Chase Investment Counsel Corp ($178.38K), Avantax Planning Partners Inc. ($104.97K), XTX Topco Ltd ($26.03K), and Geode Capital Management LLC ($6.02K).

How much institutional buying is happening at ABVC BioPharma?

Institutional investors have bought a total of 137,019 shares in the last 24 months. This purchase volume represents approximately $102.88K in transactions.

Which of ABVC BioPharma's major shareholders have been selling company stock?

The following institutional investors have sold ABVC BioPharma stock in the last 24 months: XTX Topco Ltd ($7.81K).

How much institutional selling is happening at ABVC BioPharma?

Institutional investors have sold a total of 7,814 shares in the last 24 months. This volume of shares sold represents approximately $17.35K in transactions.



This page (NASDAQ:ABVC) was last updated on 9/5/2025 by MarketBeat.com Staff
From Our Partners